TCG Crossover Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.93M Hold
2025
Q1
$5.29M Hold
2024
Q4
$10.1M Hold
2024
Q3
$9.35M Hold
2024
Q2
$8.34M Hold
2024
Q1
$8.29M Hold
2023
Q4
$8.83M Hold
2023
Q3
$9.24M Hold
2023
Q2
$8.86M Hold
2023
Q1
$8.48M Hold
2022
Q4
$7.91M Sell
2022
Q3
$10.1M Sell
2022
Q2
$8.08M Hold
2022
Q1
$6.13M Hold
2021
Q4
$11.4M Buy